SCHEMBL6469855

SCHEMBL6469855

CCOC(=O)c1nc(SC)[nH]c1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.49
SMN1; SMN2 Q16637 2/20 0.47
TP53 P04637 1/20 0.47
HSD17B10 Q99714 1/20 0.47
ALDH1A1 P00352 3/20 0.45
CYP1A2 P05177 3/20 0.45
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
HPGD P15428 3/20 0.43
GAA P10253 1/20 0.43
PDE4D Q08499 1/20 0.42
LMNA P02545 1/20 0.42
HTT P42858 2/20 0.41
RECQL P46063 1/20 0.41
GLP1R P43220 1/20 0.41
MAPT P10636 2/20 0.40
USP2 O75604 1/20 0.40
MEN1 O00255 1/20 0.40
ALOX15 P16050 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7889798 0.85 KDM4E (0.48) KDM4EHSD17B10ALDH1A1CYP1A2CYP2C9
SCHEMBL6469853 0.82 NPSR1 (0.48) KDM4ESMN1; SMN2ALDH1A1HPGDLMNA
SCHEMBL11482936 0.80 CYP1A2 (0.47) KDM4ESMN1; SMN2TP53HSD17B10ALDH1A1
SCHEMBL1338698 0.79 SMN1; SMN2 (0.40) KDM4ESMN1; SMN2TP53HSD17B10ALDH1A1
SCHEMBL6094120 0.79 KDM4E (0.52) KDM4ESMN1; SMN2ALDH1A1CYP1A2CYP2C9
SCHEMBL4754864 0.78 KDM4E (0.55) KDM4EHSD17B10ALDH1A1CYP1A2CYP2C9
SCHEMBL5727096 0.77 KDM4E (0.48) KDM4ESMN1; SMN2TP53HSD17B10ALDH1A1
SCHEMBL9044890 0.76 KDM4E (0.36) KDM4ESMN1; SMN2TP53HSD17B10ALDH1A1
SCHEMBL4203770 0.76 L3MBTL1 (0.50) KDM4ESMN1; SMN2ALDH1A1CYP1A2CYP2C9
SCHEMBL1899259 0.74 KDM4E (0.62) KDM4ESMN1; SMN2ALDH1A1CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005011609-A2 TRIAZOLOPURINE-BASED TRICYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME BRISTOL-MYERS SQUIBB COMPANY (US) 2005-02-10 WO disclosed
WO-2004075846-A2 PYRAZOLOPURINE-BASED TRICYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME BRISTOL-MYERS SQUIBB COMPANY (US) 2004-09-10 WO disclosed
EP-0785937-A1 2-(IMIDAZOL-4-YL)CARBAPENEME DERIVATIVES, INTERMEDIATES THEREOF AND USE AS ANTIBACTERIALS SMITHKLINE BEECHAM PLC (GB) 1997-07-30 EP disclosed
WO-1996011932-A1 2-(IMIDAZOL-4-YL)CARBAPENEME DERIVATIVES, INTERMEDIATES THEREOF AND USE AS ANTIBACTERIALS SMITHKLINE BEECHAM PLC (GB) 1996-04-25 WO disclosed
EP-0605524-A1 ANTIBACTERIAL, ANTIMYCOPLASMAL COMPOUNDS RELATED TO MUPIROCIN SMITHKLINE BEECHAM PLC (GB) 1994-07-13 EP disclosed